ASND vs. FINV

In the year-to-date period, ASND achieves a 12.17% return, which is significantly lower than FINV's 32.36% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and FinVolution Group (FINV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ASND Sharpe Ratio is 0.34, which is lower than the FINV Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of ASND and FINV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ASND nor FINV has paid dividends to shareholders.

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum FINV drawdown of -89.64%. Use the drawdown chart below to compare losses from any high point for ASND and FINV. For additional features, visit the drawdowns tool.

Ascendis Pharma A/S (ASND) and FinVolution Group (FINV) have volatilities of 12.50% and 12.84%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Ascendis Pharma A/S and FinVolution Group. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.